Scientists test new weapon to stop deadly pancreatic Cancer's defenses
NCT ID NCT05077800
Summary
This study is testing if adding two experimental drugs to standard chemotherapy can prevent advanced pancreatic cancer from becoming resistant to treatment. The goal is to help the standard drugs work better and for longer. The study will involve about 70 adults with newly diagnosed metastatic pancreatic cancer who have not yet received any treatment for it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREATIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Charlestown, Massachusetts, 02129, United States
-
Massachusetts General Hospital Cancer Center
Boston, Massachusetts, 02114, United States
-
University of Colorado Cancer Center
Aurora, Colorado, 80045, United States
-
University of Washington School of Medicine
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.